Results 201 to 210 of about 166,330,976 (288)

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin, Binbin Xue, Dewei Xie, Jia Li, Juyuan Pan, Lanbing Zhu, Qiaowen Tong, Jing Lin, Ruofan Zhu, Xu Zhang, Junhui Xia, Xiang Li   +11 more
wiley   +1 more source

Kennedy Institue of Ethics Member's Newsletter, Spring 2007

, 2007

core  

Impact of war on oral health among the Gaza population: a comparative cross-sectional study. [PDF]

BMC Oral Health
Awad A, Altos O, Bashah A, Madi Z, Fahumy SM, Musleh A, AbuNasser B, Jiang H.   +7 more
europepmc   +1 more source

Neurovascular Contacts in the Pathophysiology of Neuralgic Amyotrophy: An Observational Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neuralgic amyotrophy (NA) is a prevalent, monophasic, multifocal immune‐mediated neuropathy. A distinctive characteristic of the disease is the occurrence of nerve or fascicle constrictions and torsions (NA‐associated focal nerve lesions, NAFL). The pathophysiology underlying this phenomenon remains to be fully elucidated.
Johannes Fabian Holle, Andreas Leha, Volker Limmroth, Wolfram Windisch, Maximilian Zimmermann   +4 more
wiley   +1 more source

Kennedy Institue of Ethics Member's Newsletter, Spring 2009

, 2009

core  

Cervical screening under wartime: resilience and quality of laboratory services in Ukraine during the Russian invasion. [PDF]

Front Public Health
Botsun P, Omelianenko I, Sava Y, Panko M, Natrus L, Kobyliak N, Sulaieva O.   +6 more
europepmc   +1 more source

Ethics of War as a Part of Military Ethics [PDF]

, 2016
openaire   +1 more source

Long‐Term Efficacy of Immunotherapy in Autoimmune Autonomic Ganglionopathy—A 10‐Year Follow Up Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Autoimmune autonomic ganglionopathy (AAG) is a rare but potentially treatable cause of severe autonomic failure. Evidence guiding long‐term immunotherapy, treatment sequencing, and residual autonomic impairment is limited. We evaluated long‐term treatment response, residual autonomic dysfunction, and relapse patterns in patients with
Giacomo Chiaro, Shiwen Koay, Gordon T. Ingle, Patricia McNamara, Laura Watson, Fion Bremner, Valeria Iodice   +6 more
wiley   +1 more source

Kennedy Institue of Ethics Member's Newsletter, Fall 2004

, 2004

core  

The effects of war on patients with Parkinson's disease. [PDF]

Clin Park Relat Disord
Salari M, Etemadifar M, Rezaei K, Hojjatipour F.   +3 more
europepmc   +1 more source